Gerard B - Search Results

1

Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanoma.

Semb KA, Aamdal S, Bohmann T, Lucas C, Gerard B. Semb KA, et al. Among authors: gerard b. Melanoma Res. 1998 Dec;8(6):565-72. doi: 10.1097/00008390-199812000-00012. Melanoma Res. 1998. PMID: 9918419 Clinical Trial.

2

Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma--an effective combination with unexpected toxicity.

Aamdal S, Gerard B, Bohman T, D'Incalci M. Aamdal S, et al. Among authors: gerard b. Eur J Cancer. 1992;28(2-3):447-50. doi: 10.1016/s0959-8049(05)80074-7. Eur J Cancer. 1992. PMID: 1591062

3

Activity and unexpected lung toxicity of the sequential administration of two alkylating agents--dacarbazine and fotemustine--in patients with melanoma.

Gerard B, Aamdal S, Lee SM, Leyvraz S, Lucas C, D'Incalci M, Bizzari JP. Gerard B, et al. Eur J Cancer. 1993;29A(5):711-9. doi: 10.1016/s0959-8049(05)80352-1. Eur J Cancer. 1993. PMID: 8471329

4

Fotemustine--an advance in the treatment of metastatic malignant melanoma.

Merimsky O, Inbar M, Gerard B, Chaitchik S. Merimsky O, et al. Among authors: gerard b. Melanoma Res. 1992 Dec;2(5-6):401-6. doi: 10.1097/00008390-199212000-00015. Melanoma Res. 1992. PMID: 1292787 Clinical Trial.

5

Combined treatment with dacarbazine, cisplatin, fotemustine and tamoxifen in metastatic malignant melanoma.

Richard MA, Grob JJ, Zarrour H, Bassères N, Bizzari JP, Gérard B, Bonerandi JJ. Richard MA, et al. Among authors: gerard b. Melanoma Res. 1998 Apr;8(2):170-4. doi: 10.1097/00008390-199804000-00012. Melanoma Res. 1998. PMID: 9610872 Clinical Trial.

6

Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.

Punt CJ, Voest EE, Tueni E, Van Oosterom AT, Backx A, De Mulder PH, Hecquet B, Lucas C, Gerard B, Bleiberg H. Punt CJ, et al. Among authors: gerard b. Br J Cancer. 1997;76(10):1376-81. doi: 10.1038/bjc.1997.563. Br J Cancer. 1997. PMID: 9374386 Free PMC article. Clinical Trial.

7

Fotemustine: an overview of its clinical activity in disseminated malignant melanoma.

Khayat D, Avril MF, Gerard B, Bertrand P, Bizzari JP, Cour V. Khayat D, et al. Among authors: gerard b. Melanoma Res. 1992 Sep;2(3):147-51. Melanoma Res. 1992. PMID: 1450667 Review.

8

Palliative therapy of melanoma patients with fotemustine. Inverse relationship between tumour load and treatment effectiveness. A multicentre phase II trial of the EORTC-Melanoma Cooperative Group (MCG).

Kleeberg UR, Engel E, Israels P, Bröcker EB, Tilgen W, Kennes C, Gérard B, Lejeune F, Glabbeke MV, Lentz MA. Kleeberg UR, et al. Among authors: gerard b. Melanoma Res. 1995 Jun;5(3):195-200. doi: 10.1097/00008390-199506000-00009. Melanoma Res. 1995. PMID: 7543785 Clinical Trial.

9

Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules.

Awada A, Giacchetti S, Gerard B, Eftekhary P, Lucas C, De Valeriola D, Poullain MG, Soudon J, Dosquet C, Brillanceau MH, Giroux B, Marty M, Bleiberg H, Calvo F, Piccart M. Awada A, et al. Among authors: gerard b. Ann Oncol. 2002 Dec;13(12):1925-34. doi: 10.1093/annonc/mdf321. Ann Oncol. 2002. PMID: 12453862 Free article. Clinical Trial.

10

Fotemustine and tamoxifen combination therapy in metastatic malignant melanoma. A phase II study.

Punt CJ, Tytgat JH, van Liessum PA, Gerard B. Punt CJ, et al. Among authors: gerard b. Eur J Cancer. 1995;31A(3):421-2. doi: 10.1016/0959-8049(94)00503-w. Eur J Cancer. 1995. PMID: 7786613 Free article. Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page